Literature DB >> 16377634

Processivity of chimeric class V myosins.

Elena B Krementsova1, Alex R Hodges, Hailong Lu, Kathleen M Trybus.   

Abstract

Unconventional myosin V takes many 36-nm steps along an actin filament before it dissociates, thus ensuring its ability to move cargo intracellularly over long distances. In the present study we assessed the structural features that affect processive run length by analyzing the properties of chimeras of mouse myosin V and a non-processive class V myosin from yeast (Myo4p) (Reck-Peterson, S. L., Tyska, M. J., Novick, P. J., and Mooseker, M. S. (2001) J. Cell Biol. 153, 1121-1126). Surprisingly a chimera containing the yeast motor domain on the neck and rod of mouse myosin V (Y-MD) showed longer run lengths than mouse wild type at low salt. Run lengths of mouse myosin V showed little salt dependence, whereas those of Y-MD decreased steeply with ionic strength, similar to a chimera containing yeast loop 2 in the mouse myosin V backbone. Loop 2 binds to acidic patches on actin in the weak binding states of the cycle (Volkmann, N., Liu, H., Hazelwood, L., Krementsova, E. B., Lowey, S., Trybus, K. M., and Hanein, D. (2005) Mol. Cell 19, 595-605). Constructs containing yeast loop 2, which has no net charge compared with +6 for wild type, showed a higher K(m) for actin in steady-state ATPase assays. The results imply that a positively charged loop 2 and a high affinity for actin are important to maintain processivity near physiologic ionic strength.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377634     DOI: 10.1074/jbc.M510041200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Motors and their tethers: the role of secondary binding sites in processive motility.

Authors:  Margaret M Kincaid; Stephen J King
Journal:  Cell Cycle       Date:  2006-12-01       Impact factor: 4.534

2.  Essential features of the class V myosin from budding yeast for ASH1 mRNA transport.

Authors:  Carol S Bookwalter; Matthew Lord; Kathleen M Trybus
Journal:  Mol Biol Cell       Date:  2009-05-28       Impact factor: 4.138

3.  A single molecule approach to mRNA transport by a class V myosin.

Authors:  Thomas E Sladewski; Kathleen M Trybus
Journal:  RNA Biol       Date:  2014-10-31       Impact factor: 4.652

4.  The Myosin IXb motor activity targets the myosin IXb RhoGAP domain as cargo to sites of actin polymerization.

Authors:  Frank van den Boom; Heiko Düssmann; Katharina Uhlenbrock; Marouan Abouhamed; Martin Bähler
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

5.  Myosin VI has a one track mind versus myosin Va when moving on actin bundles or at an intersection.

Authors:  M Yusuf Ali; Samantha B Previs; Kathleen M Trybus; H Lee Sweeney; David M Warshaw
Journal:  Traffic       Date:  2012-10-30       Impact factor: 6.215

6.  Human myosin Vc is a low duty ratio nonprocessive motor.

Authors:  Shinya Watanabe; Tomonobu M Watanabe; Osamu Sato; Junya Awata; Kazuaki Homma; Nobuhisa Umeki; Hideo Higuchi; Reiko Ikebe; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2007-12-12       Impact factor: 5.157

Review 7.  Myosin V from head to tail.

Authors:  K M Trybus
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

8.  Monomeric myosin V uses two binding regions for the assembly of stable translocation complexes.

Authors:  Alexander Heuck; Tung-Gia Du; Stephan Jellbauer; Klaus Richter; Claudia Kruse; Sigrun Jaklin; Marisa Müller; Johannes Buchner; Ralf-Peter Jansen; Dierk Niessing
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-04       Impact factor: 11.205

9.  Two single-headed myosin V motors bound to a tetrameric adapter protein form a processive complex.

Authors:  Elena B Krementsova; Alex R Hodges; Carol S Bookwalter; Thomas E Sladewski; Mirko Travaglia; H Lee Sweeney; Kathleen M Trybus
Journal:  J Cell Biol       Date:  2011-11-14       Impact factor: 10.539

10.  Engineering controllable bidirectional molecular motors based on myosin.

Authors:  Lu Chen; Muneaki Nakamura; Tony D Schindler; David Parker; Zev Bryant
Journal:  Nat Nanotechnol       Date:  2012-02-19       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.